Description

3-(2,7-Dimethyl-5,6,7,8-Tetrahydro-Benzo[4,5]-Thieno[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid is a high-purity, advanced pharmaceutical intermediate featuring a complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly for its potential role as a key building block in novel therapeutic agents. It is primarily sought by pharmaceutical R&D laboratories, biotechnology companies, and fine chemical manufacturers engaged in the synthesis of innovative small-molecule drugs.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel drug candidates targeting various therapeutic areas.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Reagent: Employed in biochemical assays and as a tool compound for investigating specific biological pathways and enzyme interactions.
• Fine Chemical Synthesis: Acts as a specialized building block for constructing complex heterocyclic molecules in custom synthesis and process development.
• Academic Research: Utilized in university and institutional laboratories for advanced organic synthesis and pharmacological studies.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing outsourced drug discovery and development services.

Basic Information

Product Name	3-(2,7-Dimethyl-5,6,7,8-Tetrahydro-Benzo[4,5]-Thieno[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid
CAS No.	886498-81-3
Molecular Formula	C17H21N3O2S
Molecular Weight	331.43 g/mol
Synonyms	3-[(2,7-Dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]propanoic acid; 3-((2,7-Dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino)propionic acid; 886498-81-3; UNII-9Q4Q1C7V7Q; 9Q4Q1C7V7Q; Propanoic acid, 3-[(2,7-dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]-; BDBM50391445; AKOS025310647.
EINECS	Contact for details

Quality Control

Our 3-(2,7-Dimethyl-5,6,7,8-Tetrahydro-Benzo[4,5]-Thieno[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis, to ensure it meets the stringent requirements for pharmaceutical research. A detailed Certificate of Analysis (COA) is provided with every shipment, guaranteeing traceability and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to exclude moisture. For long-term storage, consider desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH guidelines
Heavy Metals	< 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.